PetMed Express Q4 net loss $5.1M, revenue down 5.4%; declares $0.30 dividend

PETMED EXPRESS INC

2023-FY EPS reported $0.01 revenue$247,569,000

Q4 net loss $(5.1)M ($0.25 diluted EPS) vs net income $6.1M ($0.30) prior year.
Q4 net sales $62.4M, down 5.4% YoY; full-year sales $256.9M, down 6.1%.
Q4 Adjusted EBITDA $3.6M, down 61.8% from $9.5M; FY adj EBITDA $19.8M down 41.9%.
New customers increased 12% YoY for Q4; AutoShip & Save recurring revenue 44% of total.
Board declared $0.30/share quarterly dividend, payable June 12, record June 6, 2023.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PETMED EXPRESS INC reported financial results for fourth quarter and fiscal year ended March 31, 2023.

Period: fourth quarter and fiscal year ended March 31, 2023
Result: reported results

Exact text from the filing

On May 22, 2023, PetMed Express, Inc. (the “Company”) issued a press release announcing its March 31, 2023 fourth quarter financial results and other financial information

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-23-000027

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.